Article
Cordycepin Regulates GSK-3β/β-Catenin Signaling in Human Leukemia Cells
26 Sept 2013
Abstract excerpt
BACKGROUND: Leukemia stem cells (LSCs) are a limitless cell source for the initiation and maintenance of leukemia. Activation of the Wnt/β-catenin pathway is required for the survival and development of LSCs. Therefore, targeting β-catenin is considered a therapeutic strategy for the treatment of leukemia. The goal of this study was to explore whether cordycepin, an active component of the traditional medicine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
